P
PYXS icon

Pfizer’s Pyxis Oncology PYXS Stock Holding History

Pfizer’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.21M Hold
7,032,770
– – 3.86% 7
2025
Q4 		$8.09M Hold
7,032,770
– – 3.42% 7
2025
Q3 		$15.6M Hold
7,032,770
– – 3.57% 7
2025
Q2 		$7.74M Hold
7,032,770
– – 1.34% 7
2025
Q1 		$6.89M Hold
7,032,770
– – 1.38% 9
2024
Q4 		$11M Buy
+7,032,770
New +$20.3M 0.42% 10

Other funds holding PYXS

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return

Pfizer's PYXS Position: Q1 2026 in Review

Pfizer held its Pyxis Oncology (PYXS) position steady in Q1 2026 at 7,032,770 shares worth $9.21M. The position accounts for 3.86% of the portfolio, ranked #7.

Pfizer first reported a position in PYXS in Q4 2024 and has held it in 6 quarters since. The position peaked at $15.6M in Q3 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Pfizer held 7,032,770 shares of Pyxis Oncology worth $9.21M as of Q1 2026.
  • Pfizer left its Pyxis Oncology share count unchanged in Q1 2026.
  • Pyxis Oncology made up 3.86% of Pfizer's portfolio in Q1 2026, its #7 holding.
  • Pfizer first reported a position in Pyxis Oncology in Q4 2024 and has held it in 6 quarters since.
  • Pfizer's Pyxis Oncology position peaked at $15.6M in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Pfizer's 13F filing for Q1 2026, filed 12 May 2026.